메뉴 건너뛰기




Volumn 43, Issue 5, 2013, Pages 1467-1480

High expression of trimethylated histone H3 at lysine 27 predicts better prognosis in non-small cell lung cancer

Author keywords

DNA methylation; Enhancer of zeste homolog 2; Epigenetics; Non small cell lung cancer; Trimethylated histone H3 at lysine 27

Indexed keywords

CELL NUCLEUS ANTIGEN; HISTONE H3; LYSINE; METHYLTRANSFERASE; TRANSCRIPTION FACTOR EZH2;

EID: 84885039742     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2013.2062     Document Type: Article
Times cited : (54)

References (46)
  • 2
    • 4744344066 scopus 로고    scopus 로고
    • Epigenetics and cancer
    • Lund AH and van Lohuizen M: Epigenetics and cancer. Genes Dev 18: 2315-2335, 2004.
    • (2004) Genes Dev , vol.18 , pp. 2315-2335
    • Lund, A.H.1    Van Lohuizen, M.2
  • 3
    • 35349020543 scopus 로고    scopus 로고
    • Transcriptional silencing of hedgehog-interacting protein by cpg hypermethylation and chromatic structure in human gastrointestinal cancer
    • Taniguchi H, Yamamoto H, Akutsu N, et al: Transcriptional silencing of hedgehog-interacting protein by CpG hypermethylation and chromatic structure in human gastrointestinal cancer. J Pathol 213: 131-139, 2007.
    • (2007) J Pathol , vol.213 , pp. 131-139
    • Taniguchi, H.1    Yamamoto, H.2    Akutsu, N.3
  • 4
    • 34249774568 scopus 로고    scopus 로고
    • Transcriptional silencing of the tms1/asc tumour suppressor gene by an epigenetic mechanism in hepatocellular carcinoma cells
    • Zhang C, Li H, Zhou G, et al: Transcriptional silencing of the TMS1/ASC tumour suppressor gene by an epigenetic mechanism in hepatocellular carcinoma cells. J Pathol 212: 134-142, 2007.
    • (2007) J Pathol , vol.212 , pp. 134-142
    • Zhang, C.1    Li, H.2    Zhou, G.3
  • 5
    • 50249175130 scopus 로고    scopus 로고
    • Loss of trimethylation at lysine 27 of histone h3 is a predictor of poor outcome in breast, ovarian, and pancreatic cancers
    • Wei Y, Xia W, Zhang Z, et al: Loss of trimethylation at lysine 27 of histone H3 is a predictor of poor outcome in breast, ovarian, and pancreatic cancers. Mol Carcinog 47: 701-706, 2008.
    • (2008) Mol Carcinog , vol.47 , pp. 701-706
    • Wei, Y.1    Xia, W.2    Zhang, Z.3
  • 6
    • 11144286644 scopus 로고    scopus 로고
    • Histone h3 acetylation is associated with reduced p21(waf1/cip1) expression by gastric carcinoma
    • Mitani Y, Oue N, Hamai Y, et al: Histone H3 acetylation is associated with reduced p21(WAF1/CIP1) expression by gastric carcinoma. J Pathol 205: 65-73, 2005.
    • (2005) J Pathol , vol.205 , pp. 65-73
    • Mitani, Y.1    Oue, N.2    Hamai, Y.3
  • 7
    • 33847076849 scopus 로고    scopus 로고
    • Chromatin modifications and their function
    • Kouzarides T: Chromatin modifications and their function. Cell 128: 693-705, 2007.
    • (2007) Cell , vol.128 , pp. 693-705
    • Kouzarides, T.1
  • 8
    • 67650898226 scopus 로고    scopus 로고
    • The histone deacetylase inhibitor lbh589 inhibits expression of mitotic genes causing g2/m arrest and cell death in head and neck squamous cell carcinoma cell lines
    • Prystowsky MB, Adomako A, Smith RV, et al: The histone deacetylase inhibitor LBH589 inhibits expression of mitotic genes causing G2/M arrest and cell death in head and neck squamous cell carcinoma cell lines. J Pathol 218: 467-477, 2009.
    • (2009) J Pathol , vol.218 , pp. 467-477
    • Prystowsky, M.B.1    Adomako, A.2    Smith, R.V.3
  • 9
    • 33846569960 scopus 로고    scopus 로고
    • A stem cell-like chromatin pattern may predispose tumor suppressor genes to dna hypermethylation and heritable silencing
    • Ohm JE, McGarvey KM, Yu X, et al: A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat Genet 39: 237-242, 2007.
    • (2007) Nat Genet , vol.39 , pp. 237-242
    • Ohm, J.E.1    McGarvey, K.M.2    Yu, X.3
  • 10
    • 33846649587 scopus 로고    scopus 로고
    • Polycomb-mediated methylation on lys27 of histone h3 pre-marks genes for de novo methylation in cancer
    • Schlesinger Y, Straussman R, Keshet I, et al: Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer. Nat Genet 39: 232-236, 2007.
    • (2007) Nat Genet , vol.39 , pp. 232-236
    • Schlesinger, Y.1    Straussman, R.2    Keshet, I.3
  • 11
    • 32844459336 scopus 로고    scopus 로고
    • The polycomb group protein ezh2 directly controls dna methylation
    • Vire E, Brenner C, Deplus R, et al: The Polycomb group protein EZH2 directly controls DNA methylation. Nature 439: 871-874, 2006.
    • (2006) Nature , vol.439 , pp. 871-874
    • Vire, E.1    Brenner, C.2    Deplus, R.3
  • 13
    • 82555173684 scopus 로고    scopus 로고
    • EZH2 methyltransferase and h3k27 methylation in breast cancer
    • Yoo KH and Hennighausen L: EZH2 methyltransferase and H3K27 methylation in breast cancer. Int J Biol Sci 8: 59-65, 2012.
    • (2012) Int J Biol Sci , vol.8 , pp. 59-65
    • Yoo, K.H.1    Hennighausen, L.2
  • 14
    • 78651506355 scopus 로고    scopus 로고
    • High expression of h3k27me3 in human hepatocellular carcinomas correlates closely with vascular invasion and predicts worse prognosis in patients
    • Cai MY, Hou JH, Rao HL, et al: High expression of H3K27me3 in human hepatocellular carcinomas correlates closely with vascular invasion and predicts worse prognosis in patients. Mol Med 17: 12-20, 2011.
    • (2011) Mol Med , vol.17 , pp. 12-20
    • Cai, M.Y.1    Hou, J.H.2    Rao, H.L.3
  • 15
    • 84856110196 scopus 로고    scopus 로고
    • Global histone h3k27 methylation levels are different in localized and metastatic prostate cancer
    • Ellinger J, Kahl P, von der Gathen J, et al: Global histone H3K27 methylation levels are different in localized and metastatic prostate cancer. Cancer Invest 30: 92-97, 2012.
    • (2012) Cancer Invest , vol.30 , pp. 92-97
    • Ellinger, J.1    Kahl, P.2    Von Der Gathen, J.3
  • 16
    • 79955470771 scopus 로고    scopus 로고
    • The h3k27me3 demethylase, kdm6b, is induced by epstein-barr virus and over-expressed in hodgkin's lymphoma
    • Anderton JA, Bose S, Vockerodt M, et al: The H3K27me3 demethylase, KDM6B, is induced by Epstein-Barr virus and over-expressed in Hodgkin's lymphoma. Oncogene 30: 2037-2043, 2011.
    • (2011) Oncogene , vol.30 , pp. 2037-2043
    • Anderton, J.A.1    Bose, S.2    Vockerodt, M.3
  • 17
    • 59149096527 scopus 로고    scopus 로고
    • Prognostic significance of global histone modifications in resected squamous cell carcinoma of the esophagus
    • Tzao C, Tung HJ, Jin JS, et al: Prognostic significance of global histone modifications in resected squamous cell carcinoma of the esophagus. Mod Pathol 22: 252-260, 2009.
    • (2009) Mod Pathol , vol.22 , pp. 252-260
    • Tzao, C.1    Tung, H.J.2    Jin, J.S.3
  • 18
    • 82855172243 scopus 로고    scopus 로고
    • H3K27me3 protein is a promising predictive biomarker of patients' survival and chemoradioresistance in human nasopharyngeal carcinoma
    • Cai MY, Tong ZT, Zhu W, et al: H3K27me3 protein is a promising predictive biomarker of patients' survival and chemoradioresistance in human nasopharyngeal carcinoma. Mol Med 17: 1137-1145, 2011.
    • (2011) Mol Med , vol.17 , pp. 1137-1145
    • Cai, M.Y.1    Tong, Z.T.2    Zhu, W.3
  • 19
    • 79955513100 scopus 로고    scopus 로고
    • Aberrations of ezh2 in cancer
    • Chase A and Cross NC: Aberrations of EZH2 in cancer. Clin Cancer Res 17: 2613-2618, 2011.
    • (2011) Clin Cancer Res , vol.17 , pp. 2613-2618
    • Chase, A.1    Cross, N.C.2
  • 20
    • 79959267832 scopus 로고    scopus 로고
    • Validation of the histone methyltransferase ezh2 as a therapeutic target for various types of human cancer and as a prognostic marker
    • Takawa M, Masuda K, Kunizaki M, et al: Validation of the histone methyltransferase EZH2 as a therapeutic target for various types of human cancer and as a prognostic marker. Cancer Sci 102: 1298-1305, 2011.
    • (2011) Cancer Sci , vol.102 , pp. 1298-1305
    • Takawa, M.1    Masuda, K.2    Kunizaki, M.3
  • 21
    • 84857998198 scopus 로고    scopus 로고
    • Enhancer of zeste homolog 2 is a novel prognostic biomarker in nonsmall cell lung cancer
    • Huqun, Ishikawa R, Zhang J, et al: Enhancer of zeste homolog 2 is a novel prognostic biomarker in nonsmall cell lung cancer. Cancer 118: 1599-1606, 2012.
    • (2012) Cancer , vol.118 , pp. 1599-1606
    • Huqun Ishikawa, R.1    Zhang, J.2
  • 22
    • 82555176159 scopus 로고    scopus 로고
    • Polycomb group protein ezh2 is frequently expressed in inflammatory breast cancer and is predictive of worse clinical outcome
    • Gong Y, Huo L, Liu P, et al: Polycomb group protein EZH2 is frequently expressed in inflammatory breast cancer and is predictive of worse clinical outcome. Cancer 117: 5476-5484, 2011.
    • (2011) Cancer , vol.117 , pp. 5476-5484
    • Gong, Y.1    Huo, L.2    Liu, P.3
  • 23
    • 0141816752 scopus 로고    scopus 로고
    • EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells
    • Kleer CG, Cao Q, Varambally S, et al: EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc Natl Acad Sci USA 100: 11606-11611, 2003.
    • (2003) Proc Natl Acad Sci USA , vol.100 , pp. 11606-11611
    • Kleer, C.G.1    Cao, Q.2    Varambally, S.3
  • 24
    • 78651454089 scopus 로고    scopus 로고
    • EZH2 promotes expansion of breast tumor initiating cells through activation of raf1-beta-catenin signaling
    • Chang CJ, Yang JY, Xia W, et al: EZH2 promotes expansion of breast tumor initiating cells through activation of RAF1-beta-catenin signaling. Cancer Cell 19: 86-100, 2011.
    • (2011) Cancer Cell , vol.19 , pp. 86-100
    • Chang, C.J.1    Yang, J.Y.2    Xia, W.3
  • 25
  • 26
    • 84859099474 scopus 로고    scopus 로고
    • Increased risk for distant metastasis in patients with familial early-stage breast cancer and high ezh2 expression
    • Alford SH, Toy K, Merajver SD and Kleer CG: Increased risk for distant metastasis in patients with familial early-stage breast cancer and high EZH2 expression. Breast Cancer Res Treat 132: 429-437, 2012.
    • (2012) Breast Cancer Res Treat , vol.132 , pp. 429-437
    • Alford, S.H.1    Toy, K.2    Merajver, S.D.3    Kleer, C.G.4
  • 27
    • 33644822360 scopus 로고    scopus 로고
    • EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast
    • Bachmann IM, Halvorsen OJ, Collett K, et al: EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast. J Clin Oncol 24: 268-273, 2006.
    • (2006) J Clin Oncol , vol.24 , pp. 268-273
    • Bachmann, I.M.1    Halvorsen, O.J.2    Collett, K.3
  • 29
    • 79951723134 scopus 로고    scopus 로고
    • EZH2 regulates expression of p57 and contributes to progression of ovarian cancer in vitro and in vivo
    • Guo J, Cai J, Yu L, Tang H, Chen C and Wang Z: EZH2 regulates expression of p57 and contributes to progression of ovarian cancer in vitro and in vivo. Cancer Sci 102: 530-539, 2011.
    • (2011) Cancer Sci , vol.102 , pp. 530-539
    • Guo, J.1    Cai, J.2    Yu, L.3    Tang, H.4    Chen, C.5    Wang, Z.6
  • 30
    • 54049121723 scopus 로고    scopus 로고
    • In situ detection of methylated dna by histo endonuclease-linked detection of methylated dna sites: A new principle of analysis of dna methylation
    • Koji T, Kondo S, Hishikawa Y, An S and Sato Y: In situ detection of methylated DNA by histo endonuclease-linked detection of methylated DNA sites: a new principle of analysis of DNA methylation. Histochem Cell Biol 130: 917-925, 2008.
    • (2008) Histochem Cell Biol , vol.130 , pp. 917-925
    • Koji, T.1    Kondo, S.2    Hishikawa, Y.3    An, S.4    Sato, Y.5
  • 31
    • 18744396688 scopus 로고    scopus 로고
    • Induction of cell death in rat small intestine by ischemia reperfusion: Differential roles of fasfas ligand and bcl-2bax systems depending upon cell types
    • An S, Hishikawa Y and Koji T: Induction of cell death in rat small intestine by ischemia reperfusion: differential roles of Fas/Fas ligand and Bcl-2/Bax systems depending upon cell types. Histochem Cell Biol 123: 249-261, 2005.
    • (2005) Histochem Cell Biol , vol.123 , pp. 249-261
    • An, S.1    Hishikawa, Y.2    Koji, T.3
  • 32
    • 72849126461 scopus 로고    scopus 로고
    • Human papillomavirus infection and its possible correlation with p63 expression in cervical cancer in japan, mongolia, and myanmar
    • Shirendeb U, Hishikawa Y, Moriyama S, et al: Human papillomavirus infection and its possible correlation with p63 expression in cervical cancer in Japan, Mongolia, and Myanmar. Acta Histochem Cytochem 42: 181-190, 2009.
    • (2009) Acta Histochem Cytochem , vol.42 , pp. 181-190
    • Shirendeb, U.1    Hishikawa, Y.2    Moriyama, S.3
  • 33
    • 80052162130 scopus 로고    scopus 로고
    • Immunohistochemical analysis of histone h3 modifications in germ cells during mouse spermatogenesis
    • Song N, Liu J, An S, Nishino T, Hishikawa Y and Koji T: Immunohistochemical analysis of histone H3 modifications in germ cells during mouse spermatogenesis. Acta Histochem Cytochem 44: 183-190, 2011.
    • (2011) Acta Histochem Cytochem , vol.44 , pp. 183-190
    • Song, N.1    Liu, J.2    An, S.3    Nishino, T.4    Hishikawa, Y.5    Koji, T.6
  • 34
    • 0007384405 scopus 로고
    • Heavy metal intensification of dab-based hrp reaction product
    • Adams JC: Heavy metal intensification of DAB-based HRP reaction product. J Histochem Cytochem 29: 775, 1981.
    • (1981) J Histochem Cytochem , vol.29 , pp. 775
    • Adams, J.C.1
  • 35
    • 4544233936 scopus 로고    scopus 로고
    • Expression of keratinocyte growth factor/fibroblast growth factor-7 and its receptor in human lung cancer: Correlation with tumour proliferative activity and patient prognosis
    • Yamayoshi T, Nagayasu T, Matsumoto K, Abo T, Hishikawa Y and Koji T: Expression of keratinocyte growth factor/fibroblast growth factor-7 and its receptor in human lung cancer: correlation with tumour proliferative activity and patient prognosis. J Pathol 204: 110-118, 2004.
    • (2004) J Pathol , vol.204 , pp. 110-118
    • Yamayoshi, T.1    Nagayasu, T.2    Matsumoto, K.3    Abo, T.4    Hishikawa, Y.5    Koji, T.6
  • 36
    • 8444244786 scopus 로고    scopus 로고
    • X-tile: A new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization
    • Camp RL, Dolled-Filhart M and Rimm DL: X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res 10: 7252-7259, 2004.
    • (2004) Clin Cancer Res , vol.10 , pp. 7252-7259
    • Camp, R.L.1    Dolled-Filhart, M.2    Rimm, D.L.3
  • 37
    • 84855942931 scopus 로고    scopus 로고
    • Global histone h3 lysine 27 (h3k27) methylation levels and their prognostic relevance in renal cell carcinoma
    • Rogenhofer S, Kahl P, Mertens C, et al: Global histone H3 lysine 27 (H3K27) methylation levels and their prognostic relevance in renal cell carcinoma. BJU Int 109: 459-465, 2012.
    • (2012) BJU Int , vol.109 , pp. 459-465
    • Rogenhofer, S.1    Kahl, P.2    Mertens, C.3
  • 38
    • 84866050864 scopus 로고    scopus 로고
    • Global h3k27 trimethylation and ezh2 abundance in breast tumor subtypes
    • Holm K, Grabau D, Lovgren K, et al: Global H3K27 trimethylation and EZH2 abundance in breast tumor subtypes. Mol Oncol 6: 494-506, 2012.
    • (2012) Mol Oncol , vol.6 , pp. 494-506
    • Holm, K.1    Grabau, D.2    Lovgren, K.3
  • 39
    • 20444475352 scopus 로고    scopus 로고
    • Down-regulation of human dab2ip gene expression mediated by polycomb ezh2 complex and histone deacetylase in prostate cancer
    • Chen H, Tu SW and Hsieh JT: Down-regulation of human DAB2IP gene expression mediated by polycomb Ezh2 complex and histone deacetylase in prostate cancer. J Biol Chem 280: 22437-22444, 2005.
    • (2005) J Biol Chem , vol.280 , pp. 22437-22444
    • Chen, H.1    Tu, S.W.2    Hsieh, J.T.3
  • 40
    • 13844315463 scopus 로고    scopus 로고
    • Composition and histone substrates of polycomb repressive group complexes change during cellular differentiation
    • Kuzmichev A, Margueron R, Vaquero A, et al: Composition and histone substrates of polycomb repressive group complexes change during cellular differentiation. Proc Natl Acad Sci USA 102: 1859-1864, 2005.
    • (2005) Proc Natl Acad Sci USA , vol.102 , pp. 1859-1864
    • Kuzmichev, A.1    Margueron, R.2    Vaquero, A.3
  • 41
    • 1942503942 scopus 로고    scopus 로고
    • The functions of e(z)/ezh2-mediated methylation of lysine 27 in histone h3
    • Cao R and Zhang Y: The functions of E(Z)/EZH2-mediated methylation of lysine 27 in histone H3. Curr Opin Genet Dev 14: 155-164, 2004.
    • (2004) Curr Opin Genet Dev , vol.14 , pp. 155-164
    • Cao, R.1    Zhang, Y.2
  • 42
    • 1942502862 scopus 로고    scopus 로고
    • Different ezh2-containing complexes target methylation of histone h1 or nucleosomal histone h3
    • Kuzmichev A, Jenuwein T, Tempst P and Reinberg D: Different EZH2-containing complexes target methylation of histone H1 or nucleosomal histone H3. Mol Cell 14: 183-193, 2004.
    • (2004) Mol Cell , vol.14 , pp. 183-193
    • Kuzmichev, A.1    Jenuwein, T.2    Tempst, P.3    Reinberg, D.4
  • 43
    • 0025716265 scopus 로고
    • DNA methylation and specific protein-dna interactions
    • Molloy PL and Watt F: DNA methylation and specific protein-DNA interactions. Philos Trans R Soc Lond B Biol Sci 326: 267-275, 1990.
    • (1990) Philos Trans R Soc Lond B Biol Sci , vol.326 , pp. 267-275
    • Molloy, P.L.1    Watt, F.2
  • 44
    • 77954137460 scopus 로고    scopus 로고
    • Hypomethylation of repeated dna sequences in cancer
    • Ross JP, Rand KN and Molloy PL: Hypomethylation of repeated DNA sequences in cancer. Epigenomics 2: 245-269, 2010.
    • (2010) Epigenomics , vol.2 , pp. 245-269
    • Ross, J.P.1    Rand, K.N.2    Molloy, P.L.3
  • 45
    • 20344405446 scopus 로고    scopus 로고
    • DNA methylation disturbances as novel therapeutic target in lung cancer: Preclinical and clinical results
    • Digel W and Lubbert M: DNA methylation disturbances as novel therapeutic target in lung cancer: preclinical and clinical results. Crit Rev Oncol Hematol 55: 1-11, 2005.
    • (2005) Crit Rev Oncol Hematol , vol.55 , pp. 1-11
    • Digel, W.1    Lubbert, M.2
  • 46
    • 33846111256 scopus 로고    scopus 로고
    • Alteration of dna methyltransferases contributes to 5'cpg methylation and poor prognosis in lung cancer
    • Lin RK, Hsu HS, Chang JW, Chen CY, Chen JT and Wang YC: Alteration of DNA methyltransferases contributes to 5'CpG methylation and poor prognosis in lung cancer. Lung Cancer 55: 205-213, 2007.
    • (2007) Lung Cancer , vol.55 , pp. 205-213
    • Lin, R.K.1    Hsu, H.S.2    Chang, J.W.3    Chen, C.Y.4    Chen, J.T.5    Wang, Y.C.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.